Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
On measuring psychotherapeutic action.

Psychosomatics

Sanger M.
PMID: 5822698
Psychosomatics. 1969 May-Jun;10(3):55-7.

No abstract available.

Cite
Sanger M. On measuring psychotherapeutic action. Psychosomatics. 1969;10(3):55-7
Sanger, M. (1969). On measuring psychotherapeutic action. Psychosomatics, 10(3), 55-7.
Sanger, M. "On measuring psychotherapeutic action." Psychosomatics vol. 10,3 (1969): 55-7.
Sanger M. On measuring psychotherapeutic action. Psychosomatics. 1969 May-Jun;10(3):55-7. PMID: 5822698.
Copy Download .nbib Format: NLM
NICE guidance calls for increased recognition of anxiety disorders.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Sprinks J.
PMID: 24517656
Nurs Stand. 2014 Feb 12-18;28(24):10. doi: 10.7748/ns2014.02.28.24.10.s9.

No abstract available.

Cite
Sprinks J. NICE guidance calls for increased recognition of anxiety disorders. Nurs Stand. 2014;28(24):10doi: 10.7748/ns2014.02.28.24.10.s9.
Sprinks, J. (2014). NICE guidance calls for increased recognition of anxiety disorders. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 28(24), 10. https://doi.org/10.7748/ns2014.02.28.24.10.s9
Sprinks, Jennifer. "NICE guidance calls for increased recognition of anxiety disorders." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 28,24 (2014): 10. doi: https://doi.org/10.7748/ns2014.02.28.24.10.s9
Sprinks J. NICE guidance calls for increased recognition of anxiety disorders. Nurs Stand. 2014 Feb 12-18;28(24):10. doi: 10.7748/ns2014.02.28.24.10.s9. PMID: 24517656.
Copy Download .nbib Format: NLM
Is there anything to worry about?.

Australasian journal on ageing

Byrne G.
PMID: 28635094
Australas J Ageing. 2017 Jun;36(2):96-97. doi: 10.1111/ajag.12436.

No abstract available.

Cite
Byrne G. Is there anything to worry about?. Australas J Ageing. 2017;36(2):96-97doi: 10.1111/ajag.12436.
Byrne, G. (2017). Is there anything to worry about?. Australasian journal on ageing, 36(2), 96-97. https://doi.org/10.1111/ajag.12436
Byrne, Gerard. "Is there anything to worry about?." Australasian journal on ageing vol. 36,2 (2017): 96-97. doi: https://doi.org/10.1111/ajag.12436
Byrne G. Is there anything to worry about?. Australas J Ageing. 2017 Jun;36(2):96-97. doi: 10.1111/ajag.12436. PMID: 28635094.
Copy Download .nbib Format: NLM
[Studies of cost/effectiveness of pharmacological and psychological treatment of anxiety disorders: a literature review].

Sante mentale au Quebec

Poirier-Bisson J, Roberge P, Marchand A, Grégoire R.
PMID: 21076792
Sante Ment Que. 2010;35(1):129-52. doi: 10.7202/044801ar.

This article reviews the literature on economic studies of evidence-based cognitive-behavioral treatment and pharmacotherapy for anxiety disorders. Articles were identified through electronic search of medical and psychological databases between 1980 and 2008. Seven studies were identified and included panic...

Cite
Poirier-Bisson J, Roberge P, Marchand A, et al. Les études de coûts-efficacité des traitements pharmacologiques et psychologiques des troubles anxieux : une recension des écrits. [Studies of cost/effectiveness of pharmacological and psychological treatment of anxiety disorders: a literature review]. Sante Ment Que. 2010;35(1):129-52doi: 10.7202/044801ar.
Poirier-Bisson, J., Roberge, P., Marchand, A., & Grégoire, R. (2010). Les études de coûts-efficacité des traitements pharmacologiques et psychologiques des troubles anxieux : une recension des écrits. [Studies of cost/effectiveness of pharmacological and psychological treatment of anxiety disorders: a literature review]. Sante mentale au Quebec, 35(1), 129-52. https://doi.org/10.7202/044801ar
Poirier-Bisson, Joannie, et al. "Les études de coûts-efficacité des traitements pharmacologiques et psychologiques des troubles anxieux : une recension des écrits." [Studies of cost/effectiveness of pharmacological and psychological treatment of anxiety disorders: a literature review]. Sante mentale au Quebec vol. 35,1 (2010): 129-52. doi: https://doi.org/10.7202/044801ar
Poirier-Bisson J, Roberge P, Marchand A, Grégoire R. Les études de coûts-efficacité des traitements pharmacologiques et psychologiques des troubles anxieux : une recension des écrits. [Studies of cost/effectiveness of pharmacological and psychological treatment of anxiety disorders: a literature review]. Sante Ment Que. 2010;35(1):129-52. doi: 10.7202/044801ar. French. PMID: 21076792.
Copy Download .nbib Format: NLM
[Controlling pain and anxiety in cardiac emergencies].

Viata medicala; revista de informare profesionala si stiintifica a cadrelor medii sanitare

Panait M.
PMID: 2128151
Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit. 1990 Mar;38(3):55-8.

No abstract available.

Cite
Panait M. Combaterea durerii şi anxietăţii în urgenţele cardiace. [Controlling pain and anxiety in cardiac emergencies]. Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit. 1990;38(3):55-8
Panait, M. (1990). Combaterea durerii şi anxietăţii în urgenţele cardiace. [Controlling pain and anxiety in cardiac emergencies]. Viata medicala; revista de informare profesionala si stiintifica a cadrelor medii sanitare, 38(3), 55-8.
Panait, M. "Combaterea durerii şi anxietăţii în urgenţele cardiace." [Controlling pain and anxiety in cardiac emergencies]. Viata medicala; revista de informare profesionala si stiintifica a cadrelor medii sanitare vol. 38,3 (1990): 55-8.
Panait M. Combaterea durerii şi anxietăţii în urgenţele cardiace. [Controlling pain and anxiety in cardiac emergencies]. Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit. 1990 Mar;38(3):55-8. Romanian. PMID: 2128151.
Copy Download .nbib Format: NLM
Medication math dosage assessment anxiety in undergraduate nursing students: A systematic review.

Journal of professional nursing : official journal of the American Association of Colleges of Nursing

Owegi R, Burdick K, Cannon E, McQuiston L, Arvin S.
PMID: 34187672
J Prof Nurs. 2021 Jul-Aug;37(4):735-740. doi: 10.1016/j.profnurs.2021.05.003. Epub 2021 May 07.

BACKGROUND: Medication calculation assessment is commonplace in undergraduate nursing programs. A test is routinely used to assist in the determination of safe medication administration practice in a clinical setting. Multiple factors negatively impact student performance.AIM: The aim of this...

Cite
Owegi R, Burdick K, Cannon E, et al. Medication math dosage assessment anxiety in undergraduate nursing students: A systematic review. J Prof Nurs. 2021;37(4):735-740doi: 10.1016/j.profnurs.2021.05.003.
Owegi, R., Burdick, K., Cannon, E., McQuiston, L., & Arvin, S. (2021). Medication math dosage assessment anxiety in undergraduate nursing students: A systematic review. Journal of professional nursing : official journal of the American Association of Colleges of Nursing, 37(4), 735-740. https://doi.org/10.1016/j.profnurs.2021.05.003
Owegi, Robert, et al. "Medication math dosage assessment anxiety in undergraduate nursing students: A systematic review." Journal of professional nursing : official journal of the American Association of Colleges of Nursing vol. 37,4 (2021): 735-740. doi: https://doi.org/10.1016/j.profnurs.2021.05.003
Owegi R, Burdick K, Cannon E, McQuiston L, Arvin S. Medication math dosage assessment anxiety in undergraduate nursing students: A systematic review. J Prof Nurs. 2021 Jul-Aug;37(4):735-740. doi: 10.1016/j.profnurs.2021.05.003. Epub 2021 May 07. PMID: 34187672.
Copy Download .nbib Format: NLM
Medicinal Marijuana, Stress, Anxiety, and Depression: .

Missouri medicine

Gold M.
PMID: 33311739
Mo Med. 2020 Sep-Oct;117(5):406-411.

No abstract available.

Cite
Gold M. Medicinal Marijuana, Stress, Anxiety, and Depression: . Mo Med. 2020;117(5):406-411
Gold, M. (2020). Medicinal Marijuana, Stress, Anxiety, and Depression: . Missouri medicine, 117(5), 406-411.
Gold, Mark. "Medicinal Marijuana, Stress, Anxiety, and Depression: ." Missouri medicine vol. 117,5 (2020): 406-411.
Gold M. Medicinal Marijuana, Stress, Anxiety, and Depression: . Mo Med. 2020 Sep-Oct;117(5):406-411. PMID: 33311739; PMCID: PMC7723145.
Copy Download .nbib Format: NLM
Understanding the anxious patient.

The Practitioner

Spurrell M.
PMID: 8995891
Practitioner. 1996 Dec;240(1569):700-3.

No abstract available.

Cite
Spurrell M. Understanding the anxious patient. Practitioner. 1996;240(1569):700-3
Spurrell, M. (1996). Understanding the anxious patient. The Practitioner, 240(1569), 700-3.
Spurrell, M. "Understanding the anxious patient." The Practitioner vol. 240,1569 (1996): 700-3.
Spurrell M. Understanding the anxious patient. Practitioner. 1996 Dec;240(1569):700-3. PMID: 8995891.
Copy Download .nbib Format: NLM
Premedicating the anxious patient.

Dental survey

Jacobson S.
PMID: 5219593
Dent Surv. 1966 Jun;42(6):54-8.

No abstract available.

Cite
Jacobson S. Premedicating the anxious patient. Dent Surv. 1966;42(6):54-8
Jacobson, S. (1966). Premedicating the anxious patient. Dental survey, 42(6), 54-8.
Jacobson, S. "Premedicating the anxious patient." Dental survey vol. 42,6 (1966): 54-8.
Jacobson S. Premedicating the anxious patient. Dent Surv. 1966 Jun;42(6):54-8. PMID: 5219593.
Copy Download .nbib Format: NLM
Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review.

Complementary therapies in clinical practice

Bougea A, Koros C, Simitsi AM, Chrysovitsanou C, Leonardos A, Stefanis L.
PMID: 32351233
Complement Ther Clin Pract. 2020 May;39:101154. doi: 10.1016/j.ctcp.2020.101154. Epub 2020 Mar 31.

OBJECTIVES: 1) to evaluate the efficacy of medical cannabinoids (MC) by appraising the quality of evidence from clinical studies 2) to explore the factors hampering the MC use in clinical practice of Parkinson's disease (PD).METHODS: We performed a systematic...

Cite
Bougea A, Koros C, Simitsi AM, et al. Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review. Complement Ther Clin Pract. 2020;39:101154doi: 10.1016/j.ctcp.2020.101154.
Bougea, A., Koros, C., Simitsi, A. M., Chrysovitsanou, C., Leonardos, A., & Stefanis, L. (2020). Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review. Complementary therapies in clinical practice, 39101154. https://doi.org/10.1016/j.ctcp.2020.101154
Bougea, Anastasia, et al. "Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review." Complementary therapies in clinical practice vol. 39 (2020): 101154. doi: https://doi.org/10.1016/j.ctcp.2020.101154
Bougea A, Koros C, Simitsi AM, Chrysovitsanou C, Leonardos A, Stefanis L. Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review. Complement Ther Clin Pract. 2020 May;39:101154. doi: 10.1016/j.ctcp.2020.101154. Epub 2020 Mar 31. PMID: 32351233.
Copy Download .nbib Format: NLM
[Gut microbiome as a therapeutic target in the treatment of depression and anxiety].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Katasonov AB.
PMID: 34932298
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):129-135. doi: 10.17116/jnevro2021121111129.

There is a bi-directional connection between the gut microbiome and the brain. Changes in the composition of the microbiome affect emotions, behavior, and the stress response involved in the pathogenesis of depression. Depression and anxiety are often associated with...

Cite
Katasonov AB. Kishechnyi mikrobiom kak terapevticheskaya mishen' pri lechenii depressii i trevogi. [Gut microbiome as a therapeutic target in the treatment of depression and anxiety]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):129-135doi: 10.17116/jnevro2021121111129.
Katasonov, A. B. (2021). Kishechnyi mikrobiom kak terapevticheskaya mishen' pri lechenii depressii i trevogi. [Gut microbiome as a therapeutic target in the treatment of depression and anxiety]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 121(11), 129-135. https://doi.org/10.17116/jnevro2021121111129
Katasonov, A B. "Kishechnyi mikrobiom kak terapevticheskaya mishen' pri lechenii depressii i trevogi." [Gut microbiome as a therapeutic target in the treatment of depression and anxiety]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 121,11 (2021): 129-135. doi: https://doi.org/10.17116/jnevro2021121111129
Katasonov AB. Kishechnyi mikrobiom kak terapevticheskaya mishen' pri lechenii depressii i trevogi. [Gut microbiome as a therapeutic target in the treatment of depression and anxiety]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):129-135. doi: 10.17116/jnevro2021121111129. Russian. PMID: 34932298.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries